Bio-Rad Laboratories Inc (BIO)
Return on assets (ROA)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | -1,844,202 | -778,694 | -1,325,609 | -322,369 | -637,323 | -153,537 | -424,026 | -188,960 | -3,627,532 | -6,034,686 | -1,942,424 | -101,126 | 4,245,898 | 6,658,660 | 4,045,450 | 4,097,765 | 3,806,263 | 3,520,647 | 1,947,011 | 1,579,392 |
Total assets | US$ in thousands | 9,364,100 | 10,603,500 | 9,688,450 | 12,609,900 | 12,299,100 | 11,895,900 | 11,978,200 | 13,667,400 | 13,501,700 | 12,058,500 | 12,682,100 | 14,373,700 | 17,775,800 | 19,953,400 | 15,117,600 | 13,933,200 | 12,972,600 | 12,020,900 | 10,097,300 | 8,684,360 |
ROA | -19.69% | -7.34% | -13.68% | -2.56% | -5.18% | -1.29% | -3.54% | -1.38% | -26.87% | -50.05% | -15.32% | -0.70% | 23.89% | 33.37% | 26.76% | 29.41% | 29.34% | 29.29% | 19.28% | 18.19% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $-1,844,202K ÷ $9,364,100K
= -19.69%
Based on the provided data, Bio-Rad Laboratories Inc's Return on Assets (ROA) has shown a fluctuating trend over the observed period from March 31, 2020, to December 31, 2024. The ROA started on a positive note, gradually increasing from 18.19% in March 2020 to a peak of 33.37% in September 2021. This indicates that the company was generating substantial earnings relative to its assets during this period.
However, the ROA started declining after September 2021, reaching negative values by March 2022. This signifies that the company's asset utilization and profitability deteriorated, resulting in net losses relative to its total assets. The negative trend continued through December 2024, with the ROA fluctuating between -1.29% and -19.69%.
The declining ROA indicates potential challenges in efficiently utilizing Bio-Rad Laboratories Inc's assets to generate profits, which could be attributed to various factors such as increasing costs, declining revenues, or inefficiencies in operations. It suggests that the company may need to review its strategies and operations to improve asset performance and profitability in the future.
Peer comparison
Dec 31, 2024